Roger D. Weiss, MD

Division of Alcohol, Drugs, and Addiction, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

  • 13Articles
  • 36.3KReads
  • 1998–2026Active
  • 63Collaborators
  • 696Citations

About

Roger D. Weiss, MD, is affiliated with the Division of Alcohol, Drugs, and Addiction at McLean Hospital in Belmont, Massachusetts, and the Department of Psychiatry at Harvard Medical School in Boston, Massachusetts. His work, published between 1998 and 2026, focuses on addiction and bipolar disorder. He has frequently collaborated with Margaret L. Griffin, Garrett M. Fitzmaurice, Andrew A. Nierenberg, Dana Wyner, and Gary S. Sachs.

Publications

JCP
Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes
Original Research

Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes

January 14, 2026

Even very low levels of opioid use in the first 2–3 weeks of buprenorphine treatment signal risk for poor outcomes.
, , , et al
JCP
Article

Opioid Abstinence Over 42-Month Follow-Up

March 26, 2019

Which treatments are strongly associated with opioid abstinence over time among patients with prescription opioid dependence: Opioid agonists? Outpatient counseling? Mutual-help group attendance?
, , , et al
JCP
Article

Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population

December 23, 2014

, , , et al
JCP
Original Research

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

January 10, 2012

, , , et al
JCP
Original Research

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

May 18, 2010

, , , et al
JCP
Original Research

Depression Precipitated by Alcohol Use in Patients With Co-Occurring Bipolar and Substance Use Disorders

December 30, 2009

, , , et al
JCP
Original Research

Neurocognitive Impairment and Psychosis in Bipolar I Disorder During Early Remission From an Acute Episode of Mood Disturbance

November 17, 2009

,
JCP
Original Research

Adherence to Pharmacotherapy in Bipolar Disorder Patients With and Without Co-Occurring Substance Use Disorders

August 15, 2007

, , , et al
JCP
Original Research

The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder

December 15, 2006

, , , et al
JCP
Original Research

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

June 15, 2005

, , , et al
JCP
Original Research

Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem?

February 15, 2003

, , , et al
JCP
Original Research

Group Therapy for Patients With Bipolar Disorder and Substance Dependence: Results of a Pilot Study

October 31, 2000

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe